Molecular determinants of Yellow Fever Virus pathogenicity in Syrian Golden Hamsters: one mutation away from virulence
Abstract
Yellow fever virus (Flavivirus genus) is an arthropod-borne pathogen which can infect humans, causing a severe viscerotropic disease with a high mortality rate. Adapted viral strains allow the reproduction of yellow fever disease in hamsters with features similar to the human disease. Here, we used the Infectious Subgenomic Amplicons reverse genetics method to produce an equivalent to the hamster-virulent strain, Yellow Fever Ap7, by introducing a set of 4 synonymous and 6 non-synonymous mutations into a single subgenomic amplicon, derived from the sequence of the Asibi strain. The resulting strain, Yellow Fever Ap7M, induced a disease similar to that described for Ap7 in terms of symptoms, weight evolution, viral loads in the liver and lethality. Using the same methodology, we produced mutant strains derived from either Ap7M or Asibi viruses and investigated the role of each of Ap7M non-synonymous mutations in its in vivo phenotype. This allowed identifying key components of the virulence mechanism in hamsters. In Ap7M virus, the reversion of either E/Q27H or E/D155A mutations, led to an important reduction of both virulence and in vivo replicative fitness. In addition, the introduction of the single D155A Ap7M mutation within the E protein of the Asibi virus was sufficient to drastically modify its phenotype in hamsters towards both a greater replication efficiency and virulence. Finally, inspection of the Asibi strain E protein structure combined to in vivo testing revealed the importance of an exposed -helix in domain I, containing residues 154 and 155, for Ap7M virulence in hamsters.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Exploratory re-encoding of Yellow Fever Virus genome: new insights for the design of live-attenuated viruses
R. Klitting, T. Riziki, … X. de Lamballerie·bioRxiv·May 30, 2018
- Yellow fever vaccine propagation in primary human hepatocytes triggers antiviral and cytolytic responses
Robin D. V. Kleinert, Maike Herrmann, … Richard J. P. Brown·bioRxiv·Jan 21, 2026
- Midgut barriers prevent the replication and dissemination of the yellow fever vaccine in Aedes aegypti
L. Danet, G. Beauclair, … n. jouvenet·bioRxiv·Mar 13, 2019
- Isolation of a potently neutralizing and protective human monoclonal antibody targeting yellow fever virus
J. E. Crowe, M. Doyle, … M. Diamond·bioRxiv·Feb 28, 2022
- AT-752, a double prodrug of a guanosine nucleotide analog, inhibits yellow fever virus in a hamster model
K. Lin, S. S. Good, … A. Moussa·bioRxiv·Oct 25, 2021
- Genomic and structural features of the Yellow Fever virus from the 2016-2017 Brazilian outbreak
M. M. Gomez, F. V. S. de Abreu, … M. C. Bonaldo·bioRxiv·Aug 22, 2017